André Struglics Selected Research

aggrecanase

12/2012	Aggrecanase cleavage in juvenile idiopathic arthritis patients is minimally detected in the aggrecan interglobular domain but robust at the aggrecan C-terminus.
1/2010	Association between synovial fluid levels of aggrecan ARGS fragments and radiographic progression in knee osteoarthritis.
1/2009	Synovial fluid level of aggrecan ARGS fragments is a more sensitive marker of joint disease than glycosaminoglycan or aggrecan levels: a cross-sectional study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

André Struglics Research Topics

Disease

8	Osteoarthritis 01/2022 - 09/2012
7	Knee Osteoarthritis 01/2022 - 10/2005
5	Knee Injuries (Knee Injury) 03/2020 - 01/2009
5	Wounds and Injuries (Trauma) 10/2016 - 01/2009
4	Inflammation (Inflammations) 01/2022 - 07/2015
4	Anterior Cruciate Ligament Injuries 12/2020 - 07/2015
4	Arthritis (Polyarthritis) 10/2016 - 01/2009
3	Joint Diseases (Joint Disease) 03/2020 - 01/2009
2	Familial Osteochondritis Dissecans 01/2022 - 02/2010
2	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 03/2020 - 12/2012
2	Rheumatoid Arthritis 01/2017 - 10/2016
2	Rupture 12/2015 - 07/2015
1	Osteochondritis Dissecans 01/2022
1	Synovitis 01/2019
1	Hemorrhage 01/2018
1	Pancreatitis 01/2018
1	Necrosis 10/2016
1	Pain (Aches) 01/2016
1	Chest Pain (Chest Pains) 01/2015
1	Acute Coronary Syndrome 01/2015

Drug/Important Bio-Agent (IBA)

14	Aggrecans (Aggrecan)IBA 01/2022 - 01/2009
8	Biomarkers (Surrogate Marker)IBA 01/2022 - 01/2016
4	CytokinesIBA 10/2016 - 01/2015
3	Matrix Metalloproteinases (MMPs)IBA 12/2015 - 10/2005
3	aggrecanaseIBA 12/2012 - 01/2009
2	Metalloproteases (Metalloproteinases)IBA 01/2022 - 12/2015
2	GlycosaminoglycansIBA 12/2020 - 01/2009
2	Interleukin-6 (Interleukin 6)IBA 01/2019 - 10/2016
2	Complement System Proteins (Complement)IBA 01/2017 - 10/2016
2	Peptide Hydrolases (Proteases)FDA Link 10/2016 - 09/2010
2	Collagen Type II (Type II Collagen)IBA 01/2016 - 07/2015
2	Immunoglobulin D (IgD)IBA 01/2010 - 01/2009
1	TabletsIBA 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	ADAMTS-5 Inhibitor GLPG1972IBA 01/2022
1	N 30IBA 01/2022
1	ThrombospondinsIBA 01/2022
1	ADAMTS5 inhibitor GLPG1972IBA 01/2022
1	DisintegrinsIBA 01/2022
1	EpitopesIBA 12/2020
1	GadoliniumIBA 12/2020
1	CollagenIBA 03/2020
1	lubricinIBA 01/2020
1	InterferonsIBA 01/2019
1	Interleukin-8 (Interleukin 8)IBA 01/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2019
1	Interleukin-10 (Interleukin 10)IBA 01/2019
1	Heme (Haem)IBA 01/2018
1	OsteopontinIBA 01/2018
1	pigment epithelium-derived factorIBA 01/2017
1	Cartilage Oligomeric Matrix ProteinIBA 10/2016
1	InterleukinsIBA 10/2016
1	diphosphoric acid (pyrophosphoric acid)IBA 10/2016
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 10/2016
1	Biological ProductsIBA 01/2016
1	Alanine (L-Alanine)FDA Link 12/2015
1	Serine (L-Serine)FDA Link 12/2015
1	Arginine (L-Arginine)FDA Link 12/2015
1	Glycine (Aminoacetic Acid)FDA LinkGeneric 12/2015
1	Collagen Type I (Type I Collagen)IBA 07/2015
1	Immunoglobulin M (IgM)IBA 01/2015
1	AntibodiesIBA 09/2012
1	Anti-Idiotypic AntibodiesIBA 09/2010
1	CalpainIBA 09/2010
1	C-Type Lectins (C-Type Lectin)IBA 02/2010
1	A73025IBA 01/2009
1	Proteins (Proteins, Gene)FDA Link 10/2005
1	Matrix Metalloproteinase 3 (Stromelysin 1)IBA 10/2005

Therapy/Procedure

1	Therapeutics 01/2022
1	Exercise Therapy (Therapy, Exercise) 11/2019